The Future of Drug Discovery

Iktos Robotics

The Future of Drug Discovery

Imagine a future where the full Design-Make-Test-Analysis cycle is totally automated.

Retrosynthesis AI
Spaya

Orchestration AI

Generative AI
Makya

Synthesis
Iktos Robotics

Biological testing
Iktos Robotics

Purification & analysis
Iktos Robotics

Benefits

Transforming Drug Discovery with AI and Robotics

Our fully digitized, AI supported process collects high quality data at unprecedented speed

Speed Up Drug Discovery

Speed Up Drug Discovery

Reduce the timeline to under 24 months.

Increase Efficiency

Increase Efficiency

Enable six times more parallel projects with the same number of chemists.

Transforming Drug Discovery with AI and Robotics

Our Workflow

Step-by-Step Molecular Journey

Generative AI

Generative AI

The Autonomous Lab transforms drug discovery through a systematic molecular journey. It begins with Makya, our generative AI, which generates optimal molecules in silico.

Retrosynthesis AI

Retrosynthesis AI

These molecules are then processed by Spaya, our retrosynthesis AI, to identify synthesis routes compatible with our robots.

Orchestration AI

Orchestration AI

Ilaka, our orchestration AI, takes over to manage the entire workflow, from ordering raw materials to overseeing synthesis campaigns and directing robots to perform the chemistry.

Robot Driven Chemistry

Robot Driven Chemistry

Our Chemspeed platform allow to run 100 reactions per day in parallel across more than 40 different name reactions. 

Soon, we will integrate reaction monitoring, purification, and analysis/testing into the platform to create a fully seamless and autonomous workflow.

Transforming Drug Discovery with AI and Robotics

why iktos

Leading the Way in AI-Driven Drug Discovery

Proven Track Record

Over 60 successful collaborations with leading pharmaceutical, biotech, and academic institutions.

Broad Experience

Expertise across various target families and therapeutic areas, from hit discovery to lead optimization.

Expert Team

A highly skilled team specializing in AI-driven drug design, delivering innovative solutions and valuable results.

Proven Track Record
Broad Experience
Expert Team

Our in-house Pipeline

Our in-house pipeline showcases our capability to apply our AI and robotics technology across various stages of drug development, from target identification to preclinical candidate.

Target / PathwayTherapeutic AreasHit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
MTHFD2Inflammation auto-immune diseases
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetOncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetOncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetImmuno-oncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate

Partner with Iktos

Embark with us

Since our inception in 2016, we have consistently delivered value through over 60+ collaborations with leading pharmaceutical, biotech, and academic institutions. Our highly skilled team is dedicated to pushing the boundaries of AI-driven drug design, making us a trusted partner in your molecular odyssey.

Get Started Today

Explore how Iktos’s groundbreaking solutions can accelerate your drug discovery projects. Contact us to learn more and request a demo of our platforms.

Get Started Today